Member Info for altube

Maybe Bangladesh have realised they need to take control of their energy

Main reason is that we operate in relatively safe markets. Well run company and we should now be at pre pandemic levels. Results will be good and outlook promising.

This is the big one, far more people suffering than is realised with long Covid

Lol

Also Covid is not going away in US

https://edition.cnn.com/2022/02/24/health/covid-deaths-now-younger-unvaccinated/index.html

Is it not the highest price they paid or the highest price over the last 12 months. So yes it could be 220p. Apologies.

1. Polygon would not be buying to average down. If this was a dead duck they would have gone a while ago.
2. They presume as I do that the phase 3 trial was flawed and other trials indicate the efficacy of SNG.
3. If they increase their holding to 30% they need to make an offer of the highest price they paid over the last 12 months which 170p.

Hopefully 30+

Hi when are the next results released

Apparently I have a split personality 9 ways lol

You got me I am Ghia, Northscott, and many others. You rumbled me, my reputation in tatters lol

It’s an honour to be stalked

But for the record all AIM is a binary bet. If your don’t realise that then you should not be trading. Been around doing this for 30 years. I have lost and won. Rockhopper I made 237k in the space of a month. I sold out because the logistics of drilling made it too difficult. Bought GCM and still believe this will flourish eventually. Dealing in AIM you need to understand the potential downside which is normally zero. Never buy AIM stocks unless you are happy to lose the money.

Whose in

And so I am buying again for a swift return to the 90-100 level

I presume you are not a shareholder then

They go over 30%, this could be the first of a number of RNS buys over the coming days. If they believe in the product they can takeout the rest of the equity for 170p. Rather than £20. Makes sense if you know the product works.

Uncanny polygon buying more is massive. More
Importantly they are not in the game of throwing good money after bad

This is my view of why I am still holding

1. The US trial appears a success and is moving forward.
2. The sprinter trial it does seem there are issues.
3. The spouse of a director buying shares
4. Previous trials have shown a positive outcome
5. RM seems a genuine guy
7. Value at the moment is at base level. Any positive news from the sprinter trial after further analysis, or polygon buying or director buys this will move back up.
8. Anything positive will push the share price upwards, not to £2 in the short term but nearer £1.

Just my thoughts but as I have said the product is good the trial was not so.

It’s happened to me a couple of times. Tech bubble 2000, I had a T20 on an aim stock in two weeks of opening the position. I was 50k up. By the time it came to close the t20 I was 20k down. I was 28 and 18k in debt. I chased it and opened another t20 only to lose another 16k. So total debt 34k, all on credit cards and then two weeks later lost my job. I was in a mess and called the Samaritans, not because I was going to commit suicide but I just had no where to turn. You think that’s it game over life gone not future. Any the Samaritans takes to me got the help I needed and reassured me it was only money and there would be a way back. Anyway 20 years later, I have four kids, a beautiful wife and live in a lovely house. Yesterday on paper I lost about 30k with SNG but I still hold. But it was always a gamble and I have learnt from experience to manage risk. However, I didn’t de risk because I like most of us believe it was and still is a compelling product.

My point is at this moment in time some maybe going through a difficult time financially, hopes and dreams crushed with what SNG would bring. But don’t beat yourself up, there is always a future and I promise from the lowest of the low you can and will come back from this.

I still believe the product is good, the trial was a mess and badly designed. A larger company will look to take advantage of the current dilemma. So a major pharma can now buy this for maybe £1 rather than £10+ and get the same product and deliver a much better trial amd therefore outcome. The blessing is that there is cash in the bank so there will be no fire sale.